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Abstract
The 230-kb human cytomegalovirus genome is among the largest of the known viruses. Experiments to determine the genetic
determinants of attenuation, pathogenesis, and tissue tropism are underway; however, a lack of complete sequence data for multiple strains
and substantial problems with genetic instability during in vitro propagation create serious complications for such studies. For example,
recent findings suggest that common laboratory strains Towne and AD169 passaged in cultured human fibroblasts are missing up to 15 kb
of genetic information relative to clinical isolates. To establish standard, genetically stable genomes that can be sequenced, disseminated,
and repeatedly reconstituted to produce virus stocks, we have undertaken to clone two variants of Towne, designated Townelong and
Towneshort (referred to asTownevarRIT3) (A. Skaletskaya et al., 2001, Proc. Natl. Acad. Sci. USA 98, 7829–7834), and the pathogenic strain
Toledo into bacterial artificial chromosomes (BACs). We further demonstrate the ease with which mutagenesis can be achieved by deleting
13.5 kb from the Toledo genome using a PCR-based technique.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Human cytomegalovirus (HCMV) is a member of the
herpesvirus family and is a leading cause of birth defects
when infection is acquired by HCMV naı¨ve (seronegative)
women during pregnancy (Fowler et al., 1992). HCMV also
represents one of the major opportunistic pathogens in im-
munocompromised individuals such as bone marrow and
solid organ transplant recipients and patients with primary
acquired immune deficiency syndrome (AIDS) (Mocarski,
1996).
The 230-kb double-stranded linear DNA genome of
HCMV is among the largest of the known viruses. It con-
sists of two fused segments, the long arm and the short arm.
The long arm contains a long unique region (UL) flanked by
two inverted repeats designated the b and b sequences,
while the short arm contains a short unique region (US) also
flanked by inverted repeats, the c and c sequences (Cha et
al., 1996). The long and short arms are joined at the L/S
junction. Variable numbers of a third small repeated se-
quence called the a sequence form directly reiterated arrays
at long-arm termini and at L/S junctions, while either a
single copy or no a sequence is found at short-arm termini
(Tamashiro and Spector, 1986). Inversions of the long and
short segments of the HCMV genome result in equimolar
amounts of four possible genome arrangements or isomers
(Mocarski, 1996). Circularization of the genome prior to
DNA replication creates a fusion of the genomic termini
that is indistinguishable from the L/S junction. Within cir-
cular DNA, only two arrangements of the long and short
segments are possible (McVoy and Adler, 1994).
Isolates of HCMV derived directly from clinical samples
grow slowly in cultured human fibroblast cells, are highly
cell associated, and produce low viral titers (103 to 104
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PFU/ml of culture supernatant), but adapt following sequen-
tial passage in fibroblasts to produce more efficient growth
(Revello et al., 1998; MacCormac and Grundy, 1999; Pri-
chard et al., 2001). For example, strains Towne and AD169
were developed for potential use as attenuated live vaccines
by extensive passage in fibroblasts. Both achieve relatively
high titers (106 to 107 PFU/ml). Human volunteers vacci-
nated with a Towne-based vaccine generated HCMV-spe-
cific antibodies and cytotoxic T cell responses without sig-
nificant side effects, detectable virus excretion, or latency.
In contrast, despite low passage (9), strain Toledo
achieves relatively high titer growth in cell culture (106
PFU/ml). Toledo was used as a wild-type challenge virus in
Towne vaccine studies and was found to be pathogenic,
inducing headaches, fever, mild mononucleosis syndromes,
and transient elevation of liver enzymes (Plotkin et al.,
1976, 1984, 1998; Gonczol and Plotkin, 2001).
While HCMV is commonly propagated in human fibro-
blasts, it is believed to replicate in vivo in endothelial cells,
epithelial cells of the salivary glands and kidneys, and cells
of myeloid lineage (Sinzger et al., 1995; Hahn et al., 1998;
Soderberg-Naucler et al., 2001). Efforts have been made to
characterize the growth properties of different HCMV
strains in these presumably more biologically relevant sys-
tems, including replication in SCID-hu mouse thymic im-
plants, cultured aortic, venus, and brain endothelial cells,
bone marrow-derived and fetal liver-derived granulocyte-
macrophage progenitors, and peripheral blood monocytes
(Mocarski et al., 1993; Brown et al., 1995; Kondo et al.,
1996; Hahn et al., 1998; Riegler et al., 2000). Typically,
fibroblast-adapted strains such as AD169 and Towne repli-
cate poorly in these systems, while Toledo and clinical
isolates often replicate well (MacCormac and Grundy,
1999). Hence, inefficient replication in these systems has
been postulated to correlate with attenuation of the Towne
vaccine in vivo. However, this interpretation is complicated
by recent findings that substantial deletions and rearrange-
ments have occurred within the genomes of Towne, Toledo,
and AD169 (Cha et al., 1996) and that passage in culture
combined with plaque purification have given rise to dif-
ferent variants of AD169 and Towne in use by different
laboratories.
The full sequence of the AD169 genome was published
in 1990 (Chee et al., 1990). The variant that was sequenced,
common in laboratories in the United Kingdom, was sub-
sequently found to have a 929-bp deletion relative to the
AD169 variant in common use in the United States and
available from American Type Culture Collection (Mocar-
ski et al., 1997; Dargan et al., 1997). More recently, anal-
yses of the Toledo genome suggest that both AD169 and a
widely distributed laboratory variant of Towne had under-
gone substantial deletions of UL sequences near the b
repeat (the UL-b region) relative to the Toledo genome:
13.1 kb of UL-b sequences are missing from the Towne
variant and 15.2 kb are missing from AD169 (Cha et al.,
1996). Curiously, a conserved block of the Toledo UL-b
region is inverted relative to the Towne variant and AD169
(Cha et al., 1996). It was further noted that both the AD169
and the Towne variant have large (10 kb) b-sequence
repeats, whereas in Toledo, UL is flanked by inverted b-
sequence repeats of only 400 bp; thus, despite substantial
differences in coding capacity, the genomes of all three
viruses retain similar overall length (Prichard et al., 2001).
Recent studies have found that the Towne vaccine was in
fact a mixture of two predominant genomic variants, here-
after referred to as TownevarRIT3 and Townelong. The
widely distributed Towne laboratory variant described
above appears to be essentially identical to TownevarRIT3.
Townelong resembles Toledo. It contains the UL-b se-
quences deleted in AD169 and TownevarRIT3, and similar
to Toledo, has short b-sequence repeats (R. Spaete, personal
communication); however, unlike Toledo, the block of
UL-b sequences that is inverted in Toledo is not inverted in
Townelong. Preliminary studies suggest that clinical isolates
resemble Townelong with respect to both UL-b sequence
content and orientation (Cha et al., 1996; R. Spaete, per-
sonal communication).
Thus, in two independent occurrences (AD169 and
TownevarRIT3), serial passage in fibroblasts has resulted in
deletion of the UL-b region with compensatory size in-
creases in the b sequences, presumably to maintain normal
genome length. Inversion of the UL-b sequence block ap-
pears to be unique to Toledo. While the inversion may have
existed in the original Toledo isolate, it more likely occurred
during fibroblast adaptation since clinical isolates examined
to date have not had this inversion (Cha et al., 1996; Pri-
chard et al., 2001).
In vitro and in vivo efforts are underway to map genetic
determinants that confer cell tropisms, pathogenicity, im-
munogenicity, and attenuation to different HCMV strains.
The construction of genetic mutants and interstrain chime-
ras is essential for mapping these determinants; however,
traditional methods for genetic manipulation of HCMV via
homologous recombination require passage and purification
in human fibroblasts, and this alone may attenuate, alter
tropisms, and introduce undefined genetic heterogeneity to
the resulting recombinant viruses.
To facilitate HCMV genetic studies, we cloned the ge-
nomes of various HCMV strains in genetically stable bac-
terial artificial chromosomes (BACs). We previously re-
ported cloning of the AD169 genome as an infectious BAC
(Borst et al., 1999), and here describe cloning of genomes
from strains Toledo, Townelong, and TownevarRIT3. We
further describe the application of a rapid and efficient
PCR-based method to mutagenize these genomes using the
tools of bacterial genetics. Because BAC clones are genet-
ically stable and can be reliably mutagenized in Escherichia
coli with minimal reliance on replication in human fibro-
blasts, these reagents will provide universally standard ge-
nomes for which complete sequence data should soon be
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available and from which mutants and chimeric viruses can
be constructed for genetic studies or for development of
live-attenuated vaccines.
Results
Cloning of Toledo, Townelong, and TownevarRIT3
genomes as BACs
We previously reported cloning of the HCMV laboratory
strain AD169 genome as an infectious BAC (Borst et al.,
1999). Here, we applied the same strategy of inserting a
BAC origin and chloramphenicol-resistance (camR) gene
into the US1 to US7 regions of Toledo, TownevarRIT3, and
Townelong viruses using homologous recombination and
selection for xanthine-guanine phophoribosyltransferase
(gpt) (Greaves et al., 1995). Candidate recombinant viruses
were carefully evaluated by restriction pattern analysis and
Southern hybridization to ensure the expected genomic
structures (not shown). Circular viral DNAs from each re-
combinant were then electroporated into E. coli DH10B
host cells and camR bacterial colonies were isolated.
Differences between different BAC clones were anticipated
to arise from the existence of two isomeric forms of circular
HCMV DNA in which the UL and US segments are in different
orientations to one another, and from the variable numbers of
a-sequence repeats that can occur at L/S junctions. BAC
DNAs from multiple clones derived from each strain were
analyzed by restriction pattern analysis and Southern hybrid-
ization. EcoRI and BglII digestion of six TownevarRIT3 BAC
clones revealed several restriction fragment polymorphisms
(Fig. 1A). To clarify the nature of these polymorphisms and to
establish that these BACs accurately represent the Townevar-
RIT3 genome, hybridizations were performed using probes
specific for the BAC origin, US1, and the a sequence.
All clones exhibited the expected 5.9-kb EcoRI or 13.0-kb
BglII fragments when hybridized with the BAC origin probe
(Fig. 1B), indicating correct integration of the gpt-BAC origin
cassette into the US1–US7 region. When hybridized with the
US1 probe, five of the six clones contained BglII and EcoRI
fragments of approximately 10.0- and 9.0-kb, respectively
(Fig. 1C). Clone 4 exhibited no signal, indicating that this
clone has an aberrant structure with a deletion that includes the
US1 region (Fig. 1C) and will not be considered further. For
the remaining five clones, hybridization with the a-sequence
probe detected the same US1-containing L/S junction frag-
ments and also detected an additional L/S junction fragment in
each clone. These fragments varied only slightly in size, con-
sistent with variations in a-sequence number rather than dif-
ferences in UL orientation (Fig. 1D). Indeed, restriction maps
published for TownevarRIT3 indicate that the b-sequence re-
peats contain EcoRI restriction sites (Stinski, 1991), and there-
fore, these analyses cannot reveal differences in UL orientation.
A map of the TownevarRIT3 BACs, based on these results, is
shown in Fig. 1E.
EcoRI and BglII digests of five representative Toledo
BAC clones also revealed restriction fragment polymor-
phisms (Fig. 2A). All clones exhibited identical 5.9-kb
EcoRI or 13.0-kb BglII fragments when hybridized with the
BAC origin probe (Fig. 2B), again indicating correct inte-
gration of the BAC origin. Hybridization using the US1
probe detected BglII fragments that fell into two categories
of approximately 10.0 or 13.0 kb (Fig. 2C). This could be
explained if the BglII sites that flank the L/S junctions do
not lie within the b and c sequence repeats and if clones 1,
4, and 5 contain UL in one orientation with respect to US,
while clones 2 and 3 contain UL in the opposite orientation,
as illustrated in Fig. 2E. Hybridization with the a-sequence
probe revealed the same fragments detected by the US1
probe, confirming that these fragments represent L/S junc-
tions, but in each case a second fragment representing the
second L/S junction within the BAC clones was also ob-
served (Fig. 2D). Again, the BglII fragments were consistent
with clones 1, 4, and 5 and clones 2 and 3 representing
different orientations of UL with respect to US.
Size differences in the US1-containing EcoRI fragments
were less pronounced (9 to 10 kb) (Fig. 2C); however, an
inverse relationship was noted between the sizes of the
US1-containing (top) fragments and the additional (bottom)
fragments detected by the a-sequence probe (Fig. 2D). Such
an inverse relationship was predicted if the fragment size
differences arose from differences in UL orientation, as
shown in Fig. 2E, but not if they arose from variations in
a-sequence number. Thus, as for BglII, the EcoRI sites that
flank the L/S junctions do not lie within the Toledo b- or
c-sequence repeats.
Within a given UL orientation (as defined by the BglII
results), variations attributable to differences in a-sequence
number were also observed. For example, clones 4 and 5,
which have one UL orientation, exhibited a size difference
between their US1-containing (bottom) EcoRI fragments,
and clones 2 and 3, having the other UL orientation, exhib-
ited a size difference between their upper EcoRI fragments
(Fig. 2D). In both cases these differences were consistent
with a difference of one 500-bp a sequence at the respective
L/S junctions. Taking into consideration these naturally
occurring differences in genome structure, all of the poly-
morphisms observed in the restriction patterns for these five
Toledo BAC clones shown in Fig. 2A could be accounted
for. Maps of the Toledo BACs, based on these results, are
shown in Fig. 2E.
Ten Townelong BAC clones were analyzed using EcoRI
digestion (Fig. 3A). Again, all BAC clones contained the
expected 5.9-kb fragment when hybridized with the BAC
origin probe (Fig. 3B). As was observed for the Toledo BACs,
the sizes of US1-containing L/S junctions detected by hybrid-
ization with the US1 probe suggested that EcoRI sites that
flank the L/S junctions do not lie within the Townelong b- and
c-sequence repeats and that clones 1, 2, 4, 5, and 7–10 contain
one UL orientation, while clones 3 and 6 contain the other (Fig.
3C). In clones 4 and 5, the lower L/S junction fragments
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detected by the a-sequence probe were slightly larger than
those of the other clones with the same UL orientation (clones
1, 2, and 7-10), again indicating variations in the number of a
sequences at L/S junctions within different BAC clones (Fig.
3D). A map of the Townelong BACs, based on these results, is
shown in Fig. 3E.
Reconstitution of infectious virus from BACs
To reconstitute infectious viruses, BAC DNA was pre-
pared and transfected into permissive MRC-5 fibroblast
cells as previously described (Borst et al., 1999; Hobom et
al., 2000). Viral DNAs from BAC-reconstituted viruses and
their corresponding wild-type parental viruses were isolated
and analyzed by EcoRI digestion and Southern hybridiza-
tion. The 5.9-kb BAC origin fragment was detected in all
BAC-derived viral genomes both by ethidium bromide
staining and Southern hybridization using the BAC origin
probe (Figs. 4C, 5B, and 6B).
Fig. 4A illustrates the TownevarRIT3 genome in proto-
type orientation with letter designations and estimated sizes
of EcoRI terminal and L/S junction fragments derived from
published physical mapping studies (Stinski, 1991). Hybrid-
ization of EcoRI-digested wild-type TownevarRIT3 DNA
using the US1 probe detected the 10.5-kb UM L/S junction
fragment and 7.0-kb short-arm terminal M fragment. In
BAC-derived TownevarRIT3 genomes, analogous frag-
ments designated M* and UM* were approximately 1.5 kb
smaller (Fig. 4D) due to the introduction of an EcoRI site
within the BAC origin sequences (Fig. 4A). Hybridization
Fig. 1. BAC clones of the TownevarRIT3 genome. DNA from six different clones of TownevarRIT3-BACs (designated TowvarRIT3-BAC) was digested
with EcoRI and BglII and then separated using agarose electrophoresis (A). The DNA fragments were transferred to a nylon membrane and sequentially
hybridized using probes containing sequences from the BAC origin (B), the US1 region (C), and the a sequence (D). The fragment sizes observed in B, C,
and D were used to generate a circular map (E) representing the Towshort-BACs showing EcoRI sites outside and BglII sites inside the circle. Only sites
flanking L/S junctions are shown.
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with the a-sequence probe further detected the 4.0-kb long-
arm terminal U fragment and 3.4-kb short-arm terminal Z
fragment (Fig. 4E). Based on these terminal fragment sizes,
the UZ L/S junction fragment was predicted to be 6.9 kb.
This fragment presumably comigrated with the 7.0-kb M
fragment in wild-type TownevarRIT3 DNA, but in BAC-
derived genomes where M is replaced by the 5.5-kb M*
fragment, the 6.9-kb UZ fragment was evident (Fig. 4E).
A fragment approximately 1 kb smaller than M also
hybridized to the US1 probe (Fig. 4D). The exact nature of
this fragment is unknown; however, the observations that
this fragment failed to hybridize to the a-sequence probe
(Fig. 4E) and shifted down in size a corresponding amount
in the BAC-derived genomes (Fig. 4D) suggests that these
fragments may represent short-arm terminal M fragments
that lack an a sequence, as have been reported to occur in
genomes of strain AD169 (Tamashiro and Spector, 1986).
Similar analyses were conducted for wild-type and
BAC-derived Toledo and Townelong viruses; however,
the number of fragments detected was greater because the
Toledo and Townelong b and c sequences do not contain
EcoRI sites and hence two long-arm terminal fragments,
two short-arm terminal fragments, and four L/S junction
fragments are possible. As expected, the US1 probe re-
vealed two L/S junction fragments in wild-type Toledo
DNA that were approximately 1.5 kb smaller (9.0 and
10.0 kb) in the BAC-derived viruses. A 7.0-kb short-arm
terminal fragment analogous to the TownevarRIT3 M
fragment was similarly shifted down to a 5.5-kb fragment
(analogous to M*) in the BAC-derived Toledo genomes
Fig. 2. BAC clones of the Toledo genome. DNA from five different clones from Toledo-BAC (designated Tol-BAC) was digested with EcoRI and BglII and
then separated using agarose electrophoresis (A). The DNA fragments were transferred to a nylon membrane and sequentially hybridized using probes
containing sequences from the BAC origin (B), the US1 region (C), and the a sequence (D). The fragment sizes observed in B, C, and D were used to generate
circular maps (E) representing the Tol-BACs. EcoRI or BglII restriction sites shown inside the circle illustrate clones having UL in one orientation, whereas
sites shown outside the circle illustrate clones having UL in inverted orientation, as indicated with curved arrows. Only sites flanking L/S junctions are shown.
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(Fig. 5C). Hybridization with the a-sequence probe re-
vealed the two long-arm terminal fragments (4.0 and 5.3
kb) and the second short-arm terminal fragment (8.0 kb).
Thus, the two additional L/S junction fragments were
predicted to be 11.0 and 12.0 kb in BAC-derived Toledo
genomes, and indeed, fragments consistent with these
sizes were observed (Fig. 5D). Additional bands in the 9-
to 12-kb range most likely represent junction fragments
containing two or more a sequences. The 6.5-kb band
is not predicted but may derive from cross-hybridization,
due to the G/C richness of the probe, with a fragment
elsewhere in the viral genome.
Hybridization of EcoRI-digested wild-type Townelong
DNA using the US1 probe detected the 10.5-kb UM junc-
tion fragment and 7.0-kb short-arm terminal M fragment
(Fig. 6C), exactly as observed for TownevarRIT3. Again,
both fragments were approximately 1.5 kb smaller in BAC-
derived genomes due to insertion of the BAC origin se-
quences. Hybridization with the a-sequence probe detected
the 4.0-kb long-arm terminal U fragment and 3.4-kb short-
Fig. 3. BAC clones of the Townelong genome. DNA from 10 different clones from Townelong-BAC (designated Towlong-BAC) were digested with EcoRI and
then separated using agarose electrophoresis (A). The DNA fragments were transferred to a nylon membrane and sequentially hybridized using probes
containing sequences from the BAC origin (B), the US1 region (C), and the a sequence (D). The fragment sizes observed in B, C, and D were used to generate
circular maps (E) representing the Towlong-BACs. EcoRI restriction sites shown inside the circle illustrate clones having UL in one orientation, whereas sites
shown outside the circle illustrate clones having UL in inverted orientation, as indicated with curved arrows. Only sites flanking L/S junctions are shown.
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arm terminal Z fragment (Fig. 6D), as well as the 6.9-kb UZ
junction fragment, again as observed for TownevarRIT3.
However, a 5-kb fragment was also observed that presum-
ably represents the remaining long-arm terminal fragment,
which differs from TownevarRIT3. Thus, additional junc-
tion fragments of 7.9 and 10 kb were predicted, and indeed,
fragments consistent with these sizes were observed (Fig.
6D). Maps illustrating the wild-type and BAC-derived
Townelong genomes based on these results are shown in Fig.
6E.
In all cases, the polymorphisms evident between individ-
ual BAC clones were no longer evident between the BAC-
derived viral genomes (Figs. 4B, 5A, and 6A). This obser-
vation supports the hypothesis that these polymorphisms
arise from the freezing of viral genomes with specific UL/US
orientations and specific numbers of a sequences at L/S
junctions. Upon viral replication, equivalent populations of
the four genomic isomers are generated and similar distri-
butions of L/S junctions having varying numbers of a se-
quences are established. Thus, each BAC clone, regardless
of orientation or a-sequence content, is capable restoring the
full complement of genomic heterogeneity upon viral DNA
replication and packaging.
Generation of a Toledo UL-b deletion mutant by PCR
mutagenesis
Mutagenesis of BAC-cloned genomes will be critical for
their utility in HCMV genetics. Recent PCR-based methods
for mutagenesis in E. coli are particularly attractive since
they do not require construction of recombination shuttle
plasmids containing large stretches of sequences homolo-
gous to the target region in the BAC (Shizuya et al., 1992;
Muyrers et al., 2000). We used PCR mutagenesis to intro-
duce a kanamycin-resistance (kanR) marker into the Toledo-
BAC while deleting 13.5 kb from the UL-b region. As
illustrated in Fig. 7, primers were synthesized with homol-
Fig. 4. Viral genomes reconstituted from TownevarRIT3 BACs. Maps of wild-type and BAC-derived TownevarRIT3 genomes (designated RVTowvarRIT3)
are shown (A) based on published physical mapping studies (Stinski, 1991). Only sites flanking L/S junctions and termini are shown. Viral DNA from
wild-type TownevarRIT3 and six BAC-derived RVTownevarRIT3 viruses were digested with EcoRI and separated using agarose electrophoresis (B). The
DNA fragments were transferred to a nylon membrane and sequentially hybridized using probes containing sequences from the BAC origin (C), the US1
region (D), and the a sequence (E). The positions of specific terminal and junction fragments are indicated for wild-type (left) and BAC-derived (right) viruses
and the fragment sizes (kb) are shown within parentheses.
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ogy to sequences flanking the region to be deleted and tailed
onto sequences designed to amplify a kanR cassette from a
target plasmid. The resulting PCR product was recombined
into the BAC using bacteriophage  red-, -, and -
recombination functions and colonies containing recombi-
nant BACs were isolated on plates containing kanamycin
and chloramphenicol. Candidate BAC clones as well as
reconstituted viral genomes were again screened by EcoRI
and HindIII digestion and Southern hybridization to confirm
the expected structure (not shown). The resulting mutant
BAC was named TolUL-b.
Growth characteristics of BAC-derived viruses and
RVTolUL-b
To assess the growth characteristics of BAC-derived
viruses and the mutant RVTolUL-b, growth curves
were conducted using multiplicities of infection (m.o.i.s)
Fig. 5. Viral genomes reconstituted from Toledo BACs. Viral DNA from wild-type Toledo and five BAC-derived Toledo viruses (designated RVTol) were
digested with EcoRI and separated using agarose electrophoresis (A). The DNA fragments were transferred to a nylon membrane and sequentially hybridized
using probes containing sequences from the BAC origin (B), the US1 region (C), and the a sequence (D). The positions of fragments are indicated for
wild-type (left) and BAC-derived (right) RVTol viruses and the fragment sizes (kb) are shown within parentheses. The fragment sizes observed in B, C, and
D were used to generate maps (E) representing wild-type and RVTol viral genomes. Only sites flanking L/S junctions and termini are shown.
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of 0.1 and 1. Titrations were conducted to determine
production of virus in culture from disrupted cell pellets.
The replication kinetics for BAC-derived Townelong,
TownevarRIT3, and Toledo viruses were indistinguish-
able from growth curves for the respective wild-type
viruses (Fig. 8). The mutant RVTolUL-b, however,
displayed a growth deficit of 2-3 logs that was indepen-
dent of m.o.i. as compared both to wild-type Toledo and
to BAC-derived Toledo viruses (Fig. 8). The observed
moderate growth deficit of the RVTolULb virus mutant
may be due to underlength of the virus genome or may be
due to deletion of as yet unidentified growth promoting
genes in ULb.
Discussion
In recent years it has become increasingly evident that
the HCMV genome is extremely pliable. Viral replication in
fibroblasts results in frequent genetic alterations that may
Fig. 6. Viral genomes reconstituted from Townelong BACs. Viral DNA from wild-type Townelong and eight BAC-derived Townelong viruses (designated
RVTowlong) were digested with EcoRI and separated using agarose electrophoresis (A). The DNA fragments were transferred to a nylon membrane and
sequentially hybridized using probes containing sequences from the BAC origin (B), the US1 region (C), and the a sequence (D). The positions of fragments
are indicated for wild-type (left) and BAC-derived (right) viruses RVTowlong and the fragment sizes (kb) are shown within parentheses. The fragment sizes
observed in B, C, and D were used to generate maps (E) representing wild-type and BAC-derived RVTowlong viral genomes. Only sites flanking L/S junctions
and termini are shown.
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arise not only from selective pressure to adapt to more
efficient growth in fibroblasts but also from random muta-
tions that become segregated and amplified due to the sto-
chastic nature of plaque purifications (Brown et al., 1995;
Cha et al., 1996; Dargan et al., 1997; Grundy et al., 1998;
Gerna et al., 2002a,b). Expansion of diploid regions within
the b sequences appears to facilitate large deletions by
maintaining the viral genome within a size-range efficient
for packaging. Such plasticity did not pose a significant
problem so long as viral genetic studies remained focused
on gene functions essential for replication in fibroblasts;
however, more recent studies address the genetic basis of
pathogenesis, attenuation, and tissue tropisms (MacCormac
and Grundy, 1999; Sinzger et al., 1999; Bolovan-Fritts and
Wiedeman, 2001). Here, the probability that viral stocks
from different laboratories or perhaps individual stocks
within a laboratory may represent genetically distinct vi-
ruses presents considerable cause for concern.
In this study we cloned the genomes of HCMV strains
Townelong and TownevarRIT3 and of the low-passage iso-
late Toledo as BACs. Viruses reconstituted from BAC
clones were shown to have wild-type growth kinetics and to
undergo normal genome isomerization. A rapid PCR-based
method was used to delete 13.5 kb from the Toledo-BAC,
including most of the UL-b region. While this virus exhib-
ited a significant growth deficit, this effect could be due to
Fig. 7. Deletion of the UL-b region by site-directed mutagenesis. Oligonucleotides having 3 homology to sequences flanking a kanR marker (black arrows)
and 5 homology to sequences flanking the region of UL-b to be deleted (gray lines) were used to PCR amplify pACYC177 DNA to generate a linear DNA
fragment containing the kanR marker flanked with short regions of HCMV homology (A). The PCR fragment was electroporated into cells that contained
the Tol-BAC and expressed the recombination functions red, - and - from plasmid pBAD (B). Colonies containing BACs in which the a kanR marker
was inserted into the UL-b region, with concomitant deletion of the intervening HCMV sequences, were selected on plates containing both kanamycin and
chloramphenicol (C).
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the loss of specific sequences, the reduction in genome
length, or both. It should also be noted that viral sequences
between US1 and US7 were deleted from these BAC-cloned
genomes to make room for the BAC origin sequences.
Future efforts will be aimed toward construction of BAC
clones with excisable origins that can reconstitute essen-
tially wild-type viral genomes as previously described (Yu
et al., 2002).
The genomes of several herpesviruses, including HCMV
(strain AD169 and Towne), have already been cloned as
BACs in E. coli (Messerle et al., 1997; Saecki et al., 1998;
Delecluse et al., 1998; Borst et al., 1999; Horsburgh et al.,
Fig. 8. Viral growth properties. Cells were infected with wild-type (-WT), BAC-derived (-RV), or mutant RVTolUL-b viruses at the indicated m.o.i.s and
washed 24 h after infection. Titers of cell-associated virus were determined on the indicated days after infection.
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1999; Smith and Enquist, 1999, 2000; Adler et al., 2000;
Marchini et al., 2001; McGregor and Schleiss, 2001; Yu et
al., 2002; Hahn et al., 2002). The availability of additional
BAC-cloned genomes from different HCMV strains will
provide genetically frozen standards that will greatly facil-
itate investigations into the genetic basis of pathogenesis,
attenuation, and tissue tropisms. Distribution of these clones
will permit all investigators to work with essentially iden-
tical strains, and investigators will be able to limit the extent
of passage in fibroblasts by periodically generating new
stocks from freshly transfected BAC DNAs. The availabil-
ity of full and accurate sequence data for each BAC-cloned
strain will facilitate design, construction, and analysis of
recombinant genomes, and it will be possible to construct
mutations in a variety of strain backgrounds or to create
interstrain chimeras with no dependence on fibroblast pas-
sage or replication competency.
Materials and methods
Virus and cell culture
HCMV strains Toledo and TownevarRIT3 were kindly
provided by Edward Mocarski, Stanford, CA, and strain
Townelong was kindly provided by Richard Spaete, Aviron,
Mountain View, CA. Viruses were propagated and titrated
by standard plaque assay using MRC-5 human fetal lung
fibroblast cells (BioWhittaker, Verviers, Belgium) cultured
in Dulbecco’s modified Eagle’s medium (DMEM)
(GIBCO-BRL) supplemented with 2 mM glutamine, 100
U/ml penicillin, 100 g/ml streptomycin, and 5% fetal bo-
vine serum (GIBCO-BRL) as described previously (Borst et
al., 1999; Hobom et al., 2000).
BAC cloning of the HCMV genomes
Recombinant viruses containing BAC origins were de-
rived from each strain essentially as described (Borst et al.,
1999; Hahn et al., 2002). Briefly, 20 g of plasmid
pEB1097, which contains HCMV flanking sequences (Borst
et al., 1999), a BAC origin, a camR gene, and gpt, was
linearized with restriction enzyme XcmI and electroporated
into 1  107 MRC-5 cells at 960 F and 220 V using a
Gene Pulser II unit (Bio-Rad). One day posttransfection
cells were superinfected with Toledo, TownevarRIT3, or
Townelong viruses at an m.o.i. of 5. Recombinant (gpt)
viruses were selected by three successive passages in the
presence of 100 M mycophenolic acid and 25 M xan-
thine, followed by limiting dilution purification. Restriction
enzyme analysis and Southern hybridization were used to
confirm that the recombinant isolates selected to represent
each strain had the expected genomic structures.
MRC-5 cells were infected with recombinant viruses
representing each strain. Circular genomic intermediates
isolated by a modified Hirt extraction procedure (Borst et
al., 1999; Hahn et al., 2002) were electroporated into E. coli
DH10B cells and camR colonies containing candidate BAC-
cloned genomes were selected, grown in Luria Bertani (LB)
broth supplemented with 12.5 g/ml chloramphenicol, and
used to prepare BAC DNA as described previously (Borst et
al., 1999; Hobom et al., 2000; Hahn et al., 2002).
PCR-based mutagenesis
Nucleotides 68 to 13,753 comprising the Toledo UL-b
region (GenBank Accession No. HCU33331) were deleted
from the Toledo-BAC and replaced with a kanR marker
using bacteriophage  recombination functions. A DNA
fragment containing a kanR cassette flanked by 70-bp ho-
mologies to sequences flanking the region to be deleted was
generated using primer 1 (5-cgc tgt agg gat aaa tag tgc gat
ggc gtt tgt ggg aga acg cag tag cga tgg gtt gcg acg tgc acc
gat tta ttc aac-3) and primer 2 (5-aac ggc gtc agg tct ttg gga
ctc atg acg cgc ggt ttt caa aat tcc ctg cgc gcg cga cgg gcg cca
gtg tta caa cca-3) in a PCR reaction with plasmid pA-
CYC177 DNA as the template. The PCR product was pu-
rified using a PCR purification kit (Qiagen, Hilden,
Germany), digested with DpnI to remove template DNA,
ethanol precipitated, and dissolved in 10 l sterile H2O.
DH10B cells containing the Toledo-BAC were rendered
competent for recombination by transformation with plas-
mid pBAD, a plasmid that encodes  red-, - and -
recombinase functions under control of an arabinose-in-
duceable promoter (Wagner et al., 2002; Datsenko and
Wanner, 2000; Hahn et al., 2002). Two milliliters of an
overnight broth culture was used to inoculate 200 ml of
fresh LB. The culture was incubated at 37°C with shaking
until it reached an OD600 of 0.2, at which time 2 ml of a
10% (w/v) solution of L-arabinose in LB was added. After
30 min incubation at 37°C with shaking, the culture was
chilled on ice for 15 min. The bacteria were washed three
times with ice-cold 10% glycerol, resuspended to a final
volume of 800 l with ice-cold 10% glycerol, and stored
frozen in at 80°C.
Recombination-competent bacteria were thawed on ice,
electroporated using a Bio-Rad Gene Pulser II (2,5 kV, 200
	, and 25 F) with 5 l PCR generated DNA, diluted into
1 ml LB, incubated at 37°C with shaking for 2 h, and then
streaked on LB agar plates containing 12.5 g/ml chloram-
phenicol and 25 g/ml kanamycin. The resulting bacterial
colonies were analyzed by restriction-enzyme analyses and
Southern hybridization for verification of the desired muta-
tion.
Nucleic acid isolation, restriction, and hybridization
Viral DNA was prepared as previously described (Borst
et al., 1999; Hahn et al., 2002). BAC DNA was prepared
using Nucleobond PC 100 columns (Macherey-Nagel, Du¨-
ren, Germany) according to the manufacturer’s instructions.
Restriction enzyme digested BAC and viral DNA samples
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were separated on 0.5% agarose gels, visualized by
ethidium bromide staining, and transferred to nylon mem-
branes. Membranes were prehybridized for 1 h and hybrid-
ized with digoxigenin-labeled probes (below) overnight at
42°C in 1.5% blocking reagent (Boehringer Mannheim,
Germany), 5 SSC, 50% formamide, 0.1% N-lauroylsar-
cosine, and 0.02% SDS, then washed twice for 5 min at
room temperature in 2 SSC, 0.1% SDS, and twice for 15
min at room temperature in 0.1% SSC plus 0.1% SDS.
Hybridized DNA fragments were visualized using an alka-
line phosphatase conjugated -digoxigenin antibody and
chemiluminescent alkaline phosphatase substrate (Boehr-
inger Mannheim), used according to the manufacturer’s
instructions, and exposure of Kodak BIOMAX MR X-ray
film.
The following probes were used for hybridization exper-
iments: the US1-specific probe consisted of a 750-bp SalI-
NotI fragment (Borst et al., 1999; Hahn et al., 2002) gel-
purified from pON2244; the BAC origin-specific probe
consisted of a 1.4-kb EcoRI-XbaI fragment gel-purified
from plasmid pKSO (Borst et al., 1999; Hahn et al., 2002);
and the a-sequence-specific probe consisted of XhoI-linear-
ized DNA from plasmid pON226X, which contains the
HCMV strain Towne a sequence originally derived from
plasmid pON226 (Mocarski et al., 1987). Probes were
nonisotopically labeled with digoxigenin using the DIG
DNA labeling kit (Boehringer Mannheim) according to the
manufacturer’s instructions.
Reconstitution of recombinant viruses
MRC-5 cells were plated into six-well dishes such that
70–80% confluency was attained the next day. The cells
were washed three times with DMEM to remove serum and
incubated in DMEM or 30 min prior to transfection. One
microgram of BAC DNA was added to 10 l SuperFect
transfection reagent (Qiagen), adjusted to a final volume of
100 l with DMEM, incubated for 30 min at room temper-
ature, and mixed with 900 l DMEM-5% FBS. The DMEM
was removed from the cells and replaced with the transfec-
tion mixture, 1 ml for each well. After incubation for 4 h at
37°C, the transfection mixture was removed and the cells
were incubated in fresh DMEM-5% FBS for 7 days, split
once, and cultured until the appearance of virus plaques
(typically by day 10 posttransfection).
Growth curves
MRC-5 cells were infected at an m.o.i. of 0.1 or 1. At
various times postinfection (p.i.) cells and supernatants
were removed. Cells were disrupted with three freeze-thaw
cycles and debris was subsequently removed by centrifuga-
tion for 5 min at 2000 rpm. Disrupted cell supernatants were
titrated in duplicate by a standard plaque assay.
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